BridgeMD
New treatment option for Psychosis
Official title Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis
ClinicalTrials.gov ID: NCT07001878
What this study is testing
What is Metformin?
Metformin is an investigational medicine, given as an once-daily, being studied as a potential treatment for psychosis.
Also referred to as Glucophage, Metformin Hydrochloride.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Canada reports some of the highest rates of cannabis use in our youth and young adult populations, among all the developed countries. Recent Health Canada surveys report that 27% of 16-19-year-olds and 32% of 20-24-year-olds have used cannabis in the past 30 days, with 16-24-year-olds showing the highest rates of daily or near-daily use.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 25
You may be able to join if
- This study will enroll individuals 18-25 years of age from the Nova Scotia Early Psychosis Program
You likely can't join if
- Current stimulant use disorder
The study team makes the final eligibility decision.
Where it's taking place
- St. John's, Newfoundland and Labrador, Canada
- Halifax, Nova Scotia, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 25 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include St. John's, Newfoundland and Labrador, Canada; Halifax, Nova Scotia, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.